Spectrum Pharmaceuticals, Inc. Announces First Quarter 2009 Corporate Update and Pipeline Review

May 18, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today reported financial results for the first quarter ended March 31, 2009.

Twitter
LinkedIn
Facebook
Email
Print

Earnings